SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-021123
Filing Date
2017-11-02
Accepted
2017-11-02 14:48:58
Documents
54
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q drrx-10q_20170930.htm 10-Q 1667887
2 EX-10.1 drrx-ex101_478.htm EX-10.1 151424
3 EX-31.1 drrx-ex311_8.htm EX-31.1 15370
4 EX-31.2 drrx-ex312_7.htm EX-31.2 15576
5 EX-32.1 drrx-ex321_6.htm EX-32.1 6082
6 EX-32.2 drrx-ex322_10.htm EX-32.2 6223
  Complete submission text file 0001564590-17-021123.txt   6207049

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT drrx-20170930.xml EX-101.INS 1473082
8 XBRL TAXONOMY EXTENSION SCHEMA drrx-20170930.xsd EX-101.SCH 35162
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drrx-20170930_cal.xml EX-101.CAL 51300
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drrx-20170930_def.xml EX-101.DEF 116418
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20170930_lab.xml EX-101.LAB 249892
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20170930_pre.xml EX-101.PRE 225819
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31615 | Film No.: 171171817
SIC: 2834 Pharmaceutical Preparations